| Year |
Citation |
Score |
| 2024 |
Fisher ML, Prantzalos ER, O'Donovan B, Anderson T, Sahoo PK, Twiss JL, Ortinski PI, Turner JR. Dynamic effects of ventral hippocampal NRG3/ERBB4 signaling on nicotine withdrawal-induced responses. Neuropharmacology. 109846. PMID 38211698 DOI: 10.1016/j.neuropharm.2024.109846 |
0.501 |
|
| 2023 |
Kumar M, Keady J, Aryal SP, Hessing M, Richards CI, Turner JR. The Role of Microglia in Sex- and Region-Specific Blood-Brain Barrier Integrity During Nicotine Withdrawal. Biological Psychiatry Global Open Science. 4: 182-193. PMID 38298802 DOI: 10.1016/j.bpsgos.2023.08.019 |
0.429 |
|
| 2023 |
Fisher ML, Prantzalos ER, Oâ Donovan B, Anderson T, Sahoo PK, Twiss JL, Ortinski PI, Turner JR. Dynamic Effects of Ventral Hippocampal NRG3/ERBB4 Signaling on Nicotine Withdrawal-Induced Responses. Biorxiv : the Preprint Server For Biology. PMID 36711798 DOI: 10.1101/2023.01.17.524432 |
0.499 |
|
| 2022 |
Keady J, Fisher M, Anderson E, LeMalenfant R, Turner J. Age Specific Impacts of Nicotine and Withdrawal on Hippocampal Neuregulin Signaling. The European Journal of Neuroscience. PMID 35899607 DOI: 10.1111/ejn.15780 |
0.361 |
|
| 2022 |
Keady JV, Turner J. Sex- and region-specific consequences of chronic nicotine in the murine hippocampus during fear extinction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35560579 DOI: 10.1096/fasebj.2022.36.S1.R2017 |
0.318 |
|
| 2022 |
Prantzalos E, Turner J. Role of Neuregulin 3-ErbB4 Signaling in a Murine Model of Co-Morbid Nicotine Dependence and Schizophrenia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35552899 DOI: 10.1096/fasebj.2022.36.S1.R4863 |
0.411 |
|
| 2021 |
Custodio L, Malone S, Bardo MT, Turner JR. Nicotine and Opioid Co-Dependence: Findings from Bench Research to Clinical Trials. Neuroscience and Biobehavioral Reviews. PMID 34968525 DOI: 10.1016/j.neubiorev.2021.12.030 |
0.364 |
|
| 2020 |
Fisher ML, Pauly JR, Froeliger B, Turner JR. Translational Research in Nicotine Addiction. Cold Spring Harbor Perspectives in Medicine. PMID 32513669 DOI: 10.1101/Cshperspect.A039776 |
0.452 |
|
| 2020 |
Kumar M, Adeluyi A, Anderson EL, Turner JR. Glial cells as therapeutic targets for smoking cessation. Neuropharmacology. 108157. PMID 32461156 DOI: 10.1016/j.neuropharm.2020.108157 |
0.369 |
|
| 2020 |
Fisher M, O'Donovan B, Adeluyi A, Ortinski P, Turner J. Identifying Neural Correlates of Nicotine Withdrawal in Mice: The Neuregulin Signaling Pathway The Faseb Journal. 34: 1-1. DOI: 10.1096/fasebj.2020.34.s1.08651 |
0.359 |
|
| 2019 |
Adeluyi A, Guerin L, Fisher ML, Galloway A, Cole RD, Chan SSL, Wyatt MD, Davis SW, Freeman LR, Ortinski PI, Turner JR. Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal. Science Advances. 5: eaax7031. PMID 31633029 DOI: 10.1126/sciadv.aax7031 |
0.511 |
|
| 2019 |
Fowler CD, Turner JR, Imad Damaj M. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. Handbook of Experimental Pharmacology. PMID 31267166 DOI: 10.1007/164_2019_252 |
0.533 |
|
| 2017 |
Zhou L, Fisher ML, Cole RD, Gould TJ, Parikh V, Ortinski PI, Turner JR. Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29114105 DOI: 10.1038/npp.2017.278 |
0.513 |
|
| 2016 |
Fisher M, LeMalefant R, Zhou L, Huang G, Turner J. Distinct Roles of CREB within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27848935 DOI: 10.1038/npp.2016.257 |
0.435 |
|
| 2015 |
Forcelli PA, Turner JR, Lee BG, Olson TT, Xie T, Xiao Y, Blendy JA, Kellar KJ. Anxiolytic- and Antidepressant-like Effects of the Methadone Metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP). Neuropharmacology. PMID 26365569 DOI: 10.1016/J.Neuropharm.2015.09.012 |
0.752 |
|
| 2015 |
Gomez AM, Altomare D, Sun WL, Midde NM, Ji H, Shtutman M, Turner JR, Creek KE, Zhu J. Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26232787 DOI: 10.1093/Ijnp/Pyv090 |
0.336 |
|
| 2015 |
Mague SD, Port RG, McMullen ME, Carlson GC, Turner JR. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function. Neuropharmacology. PMID 25986698 DOI: 10.1016/J.Neuropharm.2015.04.032 |
0.716 |
|
| 2014 |
Yohn NL, Turner JR, Blendy JA. Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 349: 348-54. PMID 24627467 DOI: 10.1124/Jpet.113.211706 |
0.793 |
|
| 2014 |
Hussmann GP, DeDominicis KE, Turner JR, Yasuda RP, Klehm J, Forcelli PA, Xiao Y, Richardson JR, Sahibzada N, Wolfe BB, Lindstrom J, Blendy JA, Kellar KJ. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain. Journal of Neurochemistry. 129: 721-31. PMID 24422997 DOI: 10.1111/Jnc.12653 |
0.786 |
|
| 2014 |
Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Molecular Psychiatry. 19: 801-10. PMID 23999525 DOI: 10.1038/Mp.2013.104 |
0.752 |
|
| 2013 |
Ortinski PI, Turner JR, Pierce RC. Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9451-61. PMID 23719812 DOI: 10.1523/Jneurosci.5730-12.2013 |
0.335 |
|
| 2013 |
Turner JR, Wilkinson DS, Poole RL, Gould TJ, Carlson GC, Blendy JA. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2035-47. PMID 23624742 DOI: 10.1038/Npp.2013.105 |
0.762 |
|
| 2013 |
Turner JR, Gold A, Schnoll R, Blendy JA. Translational research in nicotine dependence. Cold Spring Harbor Perspectives in Medicine. 3: a012153. PMID 23335115 DOI: 10.1101/Cshperspect.A012153 |
0.711 |
|
| 2013 |
Balu DT, Turner JR, Brookshire BR, Hill-Smith TE, Blendy JA, Lucki I. Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice. Neuropharmacology. 67: 503-10. PMID 23220293 DOI: 10.1016/J.Neuropharm.2012.11.027 |
0.588 |
|
| 2013 |
Turner JR, Ecke LE, Briand LA, Haydon PG, Blendy JA. Cocaine-related behaviors in mice with deficient gliotransmission. Psychopharmacology. 226: 167-76. PMID 23104263 DOI: 10.1007/S00213-012-2897-4 |
0.683 |
|
| 2013 |
Wilkinson DS, Turner JR, Blendy JA, Gould TJ. Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus. Psychopharmacology. 225: 201-8. PMID 22836371 DOI: 10.1007/S00213-012-2808-8 |
0.731 |
|
| 2012 |
Hussmann GP, Turner JR, Lomazzo E, Venkatesh R, Cousins V, Xiao Y, Yasuda RP, Wolfe BB, Perry DC, Rezvani AH, Levin ED, Blendy JA, Kellar KJ. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. The Journal of Pharmacology and Experimental Therapeutics. 343: 441-50. PMID 22899752 DOI: 10.1124/Jpet.112.198085 |
0.72 |
|
| 2012 |
Hilario MR, Turner JR, Blendy JA. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2661-70. PMID 22828747 DOI: 10.1038/Npp.2012.130 |
0.758 |
|
| 2012 |
Portugal GS, Wilkinson DS, Turner JR, Blendy JA, Gould TJ. Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiology of Learning and Memory. 97: 482-94. PMID 22521799 DOI: 10.1016/J.Nlm.2012.04.003 |
0.734 |
|
| 2011 |
Turner JR, Ortinski PI, Sherrard RM, Kellar KJ. Cerebellar nicotinic cholinergic receptors are intrinsic to the cerebellum: implications for diverse functional roles. Cerebellum (London, England). 10: 748-57. PMID 21562921 DOI: 10.1007/S12311-011-0285-Y |
0.704 |
|
| 2011 |
Turner JR, Castellano LM, Blendy JA. Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 41-6. PMID 21097981 DOI: 10.1093/Ntr/Ntq206 |
0.756 |
|
| 2010 |
Turner JR, Castellano LM, Blendy JA. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. The Journal of Pharmacology and Experimental Therapeutics. 334: 665-72. PMID 20435920 DOI: 10.1124/Jpet.110.166280 |
0.725 |
|
| 2006 |
Ortinski PI, Turner JR, Barberis A, Motamedi G, Yasuda RP, Wolfe BB, Kellar KJ, Vicini S. Deletion of the GABA(A) receptor alpha1 subunit increases tonic GABA(A) receptor current: a role for GABA uptake transporters. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9323-31. PMID 16957088 DOI: 10.1523/Jneurosci.2610-06.2006 |
0.55 |
|
| 2005 |
Turner JR, Kellar KJ. Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9258-65. PMID 16207885 DOI: 10.1523/Jneurosci.2112-05.2005 |
0.679 |
|
| Show low-probability matches. |